Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Acute Myeloid Leukemia Drugs
1.2 Key Market Segments
1.2.1 Acute Myeloid Leukemia Drugs Segment by Type
1.2.2 Acute Myeloid Leukemia Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Acute Myeloid Leukemia Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Acute Myeloid Leukemia Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Acute Myeloid Leukemia Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Acute Myeloid Leukemia Drugs Market Competitive Landscape
3.1 Global Acute Myeloid Leukemia Drugs Sales by Manufacturers (2019-2024)
3.2 Global Acute Myeloid Leukemia Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Acute Myeloid Leukemia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Acute Myeloid Leukemia Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Acute Myeloid Leukemia Drugs Sales Sites, Area Served, Product Type
3.6 Acute Myeloid Leukemia Drugs Market Competitive Situation and Trends
3.6.1 Acute Myeloid Leukemia Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Acute Myeloid Leukemia Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Acute Myeloid Leukemia Drugs Industry Chain Analysis
4.1 Acute Myeloid Leukemia Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Acute Myeloid Leukemia Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Acute Myeloid Leukemia Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Acute Myeloid Leukemia Drugs Sales Market Share by Type (2019-2024)
6.3 Global Acute Myeloid Leukemia Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Acute Myeloid Leukemia Drugs Price by Type (2019-2024)
7 Acute Myeloid Leukemia Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Acute Myeloid Leukemia Drugs Market Sales by Application (2019-2024)
7.3 Global Acute Myeloid Leukemia Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Acute Myeloid Leukemia Drugs Sales Growth Rate by Application (2019-2024)
8 Acute Myeloid Leukemia Drugs Market Segmentation by Region
8.1 Global Acute Myeloid Leukemia Drugs Sales by Region
8.1.1 Global Acute Myeloid Leukemia Drugs Sales by Region
8.1.2 Global Acute Myeloid Leukemia Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Acute Myeloid Leukemia Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Acute Myeloid Leukemia Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Acute Myeloid Leukemia Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Acute Myeloid Leukemia Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Ambit Biosciences Corporation
9.1.1 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Basic Information
9.1.2 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Product Overview
9.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Product Market Performance
9.1.4 Ambit Biosciences Corporation Business Overview
9.1.5 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs SWOT Analysis
9.1.6 Ambit Biosciences Corporation Recent Developments
9.2 Bristol Myers Squibb
9.2.1 Bristol Myers Squibb Acute Myeloid Leukemia Drugs Basic Information
9.2.2 Bristol Myers Squibb Acute Myeloid Leukemia Drugs Product Overview
9.2.3 Bristol Myers Squibb Acute Myeloid Leukemia Drugs Product Market Performance
9.2.4 Bristol Myers Squibb Business Overview
9.2.5 Bristol Myers Squibb Acute Myeloid Leukemia Drugs SWOT Analysis
9.2.6 Bristol Myers Squibb Recent Developments
9.3 Cephalon
9.3.1 Cephalon Acute Myeloid Leukemia Drugs Basic Information
9.3.2 Cephalon Acute Myeloid Leukemia Drugs Product Overview
9.3.3 Cephalon Acute Myeloid Leukemia Drugs Product Market Performance
9.3.4 Cephalon Acute Myeloid Leukemia Drugs SWOT Analysis
9.3.5 Cephalon Business Overview
9.3.6 Cephalon Recent Developments
9.4 Clavis Pharma
9.4.1 Clavis Pharma Acute Myeloid Leukemia Drugs Basic Information
9.4.2 Clavis Pharma Acute Myeloid Leukemia Drugs Product Overview
9.4.3 Clavis Pharma Acute Myeloid Leukemia Drugs Product Market Performance
9.4.4 Clavis Pharma Business Overview
9.4.5 Clavis Pharma Recent Developments
9.5 Eisai
9.5.1 Eisai Acute Myeloid Leukemia Drugs Basic Information
9.5.2 Eisai Acute Myeloid Leukemia Drugs Product Overview
9.5.3 Eisai Acute Myeloid Leukemia Drugs Product Market Performance
9.5.4 Eisai Business Overview
9.5.5 Eisai Recent Developments
9.6 Genzyme Corporation
9.6.1 Genzyme Corporation Acute Myeloid Leukemia Drugs Basic Information
9.6.2 Genzyme Corporation Acute Myeloid Leukemia Drugs Product Overview
9.6.3 Genzyme Corporation Acute Myeloid Leukemia Drugs Product Market Performance
9.6.4 Genzyme Corporation Business Overview
9.6.5 Genzyme Corporation Recent Developments
9.7 Sunesis Pharmaceuticals
9.7.1 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Basic Information
9.7.2 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Product Overview
9.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Product Market Performance
9.7.4 Sunesis Pharmaceuticals Business Overview
9.7.5 Sunesis Pharmaceuticals Recent Developments
9.8 Novartis
9.8.1 Novartis Acute Myeloid Leukemia Drugs Basic Information
9.8.2 Novartis Acute Myeloid Leukemia Drugs Product Overview
9.8.3 Novartis Acute Myeloid Leukemia Drugs Product Market Performance
9.8.4 Novartis Business Overview
9.8.5 Novartis Recent Developments
9.9 Eli Lilly and Company
9.9.1 Eli Lilly and Company Acute Myeloid Leukemia Drugs Basic Information
9.9.2 Eli Lilly and Company Acute Myeloid Leukemia Drugs Product Overview
9.9.3 Eli Lilly and Company Acute Myeloid Leukemia Drugs Product Market Performance
9.9.4 Eli Lilly and Company Business Overview
9.9.5 Eli Lilly and Company Recent Developments
9.10 Otsuka Holdings
9.10.1 Otsuka Holdings Acute Myeloid Leukemia Drugs Basic Information
9.10.2 Otsuka Holdings Acute Myeloid Leukemia Drugs Product Overview
9.10.3 Otsuka Holdings Acute Myeloid Leukemia Drugs Product Market Performance
9.10.4 Otsuka Holdings Business Overview
9.10.5 Otsuka Holdings Recent Developments
9.11 Takeda Pharmaceuticals
9.11.1 Takeda Pharmaceuticals Acute Myeloid Leukemia Drugs Basic Information
9.11.2 Takeda Pharmaceuticals Acute Myeloid Leukemia Drugs Product Overview
9.11.3 Takeda Pharmaceuticals Acute Myeloid Leukemia Drugs Product Market Performance
9.11.4 Takeda Pharmaceuticals Business Overview
9.11.5 Takeda Pharmaceuticals Recent Developments
10 Acute Myeloid Leukemia Drugs Market Forecast by Region
10.1 Global Acute Myeloid Leukemia Drugs Market Size Forecast
10.2 Global Acute Myeloid Leukemia Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Acute Myeloid Leukemia Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Acute Myeloid Leukemia Drugs Market Size Forecast by Region
10.2.4 South America Acute Myeloid Leukemia Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Acute Myeloid Leukemia Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Acute Myeloid Leukemia Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Acute Myeloid Leukemia Drugs by Type (2025-2030)
11.1.2 Global Acute Myeloid Leukemia Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Acute Myeloid Leukemia Drugs by Type (2025-2030)
11.2 Global Acute Myeloid Leukemia Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Acute Myeloid Leukemia Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Acute Myeloid Leukemia Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings